Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Sexually Transmitted Infections01:26

Sexually Transmitted Infections

375
Sexually transmitted infections (STIs) are diseases transmitted primarily through unsafe sexual interactions. Bacteria, viruses, or parasites cause them and can result in severe health complications if untreated.ChlamydiaThe bacterium Chlamydia trachomatis is responsible for the disease Chlamydia, the most common STI in the United States. This peculiar pathogen requires human cells to reproduce, residing intracellularly. The initial infection often goes unnoticed because it typically does not...
375
Bacterial Phylum Chlamydiae01:29

Bacterial Phylum Chlamydiae

55
The phylum Chlamydiae or Chlamydiota is composed of a single order, Chlamydiales. This phylum consists entirely of obligate intracellular parasites that infect eukaryotic hosts. While human pathogens within this group have been studied extensively, the phylum encompasses many species capable of interacting with various eukaryotic organisms. Members of Chlamydiae are typically small cocci, approximately 0.5 μm in diameter, and exhibit a distinctive developmental cycle. As is characteristic...
55
Diversity of Protists I01:15

Diversity of Protists I

65
Excavata is a diverse group of protists that includes both chemoorganotrophic and phototrophic species, with some thriving in anaerobic environments. Among the key groups within Excavata are diplomonads and parabasalids, which are flagellated protists that lack mitochondria and chloroplasts. These microorganisms typically inhabit anoxic environments, such as the intestines of animals, where they exist either symbiotically or as parasites, relying on fermentation for energy production. Some...
65
Urinary Tract Infection I: Introduction01:26

Urinary Tract Infection I: Introduction

29
Urinary tract infections (UTIs) impact various parts of the urinary system, including the kidneys, ureters, bladder, and urethra. These infections are generally bacterial, with Escherichia coli being the most common causative agent, often originating from the gastrointestinal tract. However, other bacteria, such as Staphylococcus saprophyticus, Klebsiella pneumoniae, and Proteus mirabilis, are also known to cause UTIs. The type, location, and underlying complexity of the UTI guide both...
29
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care01:30

Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care

17
A healthcare provider can diagnose a urinary tract infection (UTI) through several methods:Medical History and Symptoms: The provider will take a detailed medical history and ask about symptoms such as frequent urination, burning sensation during urination, and lower abdominal pain.Urinalysis: A clean-catch urine sample is collected in a sterile container and tested for the presence of bacteria, white blood cells (leukocytes), nitrites, blood, and protein. The presence of leukocytes and...
17
Urinary Tract Infection II: Pathophysiology01:25

Urinary Tract Infection II: Pathophysiology

23
The pathophysiology of urinary tract infections (UTIs) encompasses several progressive stages, beginning with bacterial colonization and culminating in potential systemic complications if untreated. UTIs are primarily initiated by bacteria, such as Escherichia coli, which often originate from the gastrointestinal tract and migrate to the urinary system through the periurethral area. This migration can occur via several routes, including improper hygiene practices, sexual activity, or...
23

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Implementing a Patient-Reported Outcomes Survey for Transgender and Gender-Diverse Patients at a Gender Health Clinic in the US Deep South.

Southern medical journal·2026
Same author

Transcriptomic Signatures of <i>Trichomonas vaginalis</i> Isolates That Exhibit Low, Intermediate, and High In Vitro Resistance to Metronidazole.

Microorganisms·2026
Same author

Characterization of the Clinical Manifestations of Bacterial Vaginosis at a Tertiary Care Infectious Diseases Vaginitis Clinic in the United States.

Sexually transmitted diseases·2026
Same author

Antenatal Screening for Sexually Transmitted Infections to Reduce Preterm Birth or Low Birthweight (Philani Ndiphile Study): A Randomized Three-Group Trial.

medRxiv : the preprint server for health sciences·2026
Same author

Editorial: Public health innovations inspired by transgender day of visibility.

Frontiers in public health·2026
Same author

Refining <i>Trichomonas vaginalis</i> treatment in women and men: protocol for an open-label randomised comparison of multi-dose oral metronidazole versus single-dose oral secnidazole.

BMJ open·2026

Related Experiment Video

Updated: Aug 4, 2025

A Human Fallopian Tube Model for Investigation of C. trachomatis Infections
09:11

A Human Fallopian Tube Model for Investigation of C. trachomatis Infections

Published on: August 11, 2012

13.0K

Trichomoniasis.

Olivia T Van Gerwen1, Skye A Opsteen2, Keonte J Graves1

  • 1Division of Infectious Diseases, University of Alabama at Birmingham, 703 19th Street South, ZRB 218A, Birmingham, AL 35294, USA.

Infectious Disease Clinics of North America
|April 2, 2023
PubMed
Summary
This summary is machine-generated.

Trichomoniasis, the most common nonviral STI, impacts sexual and reproductive health globally. This review covers its latest epidemiology, diagnosis, and treatment strategies.

Keywords:
Sexually transmitted infectionTrichomonas vaginalisTrichomoniasisVaginitisWomen’s health

More Related Videos

Trichuris muris Infection: A Model of Type 2 Immunity and Inflammation in the Gut
10:05

Trichuris muris Infection: A Model of Type 2 Immunity and Inflammation in the Gut

Published on: May 24, 2011

16.4K
Using Fluorescent Proteins to Visualize and Quantitate Chlamydia Vacuole Growth Dynamics in Living Cells
07:42

Using Fluorescent Proteins to Visualize and Quantitate Chlamydia Vacuole Growth Dynamics in Living Cells

Published on: October 13, 2015

7.6K

Related Experiment Videos

Last Updated: Aug 4, 2025

A Human Fallopian Tube Model for Investigation of C. trachomatis Infections
09:11

A Human Fallopian Tube Model for Investigation of C. trachomatis Infections

Published on: August 11, 2012

13.0K
Trichuris muris Infection: A Model of Type 2 Immunity and Inflammation in the Gut
10:05

Trichuris muris Infection: A Model of Type 2 Immunity and Inflammation in the Gut

Published on: May 24, 2011

16.4K
Using Fluorescent Proteins to Visualize and Quantitate Chlamydia Vacuole Growth Dynamics in Living Cells
07:42

Using Fluorescent Proteins to Visualize and Quantitate Chlamydia Vacuole Growth Dynamics in Living Cells

Published on: October 13, 2015

7.6K

Area of Science:

  • Infectious Diseases
  • Public Health
  • Reproductive Health

Background:

  • Trichomoniasis is the most common non-viral sexually transmitted infection (STI) globally.
  • It is linked to adverse sexual and reproductive health outcomes in both sexes.
  • Understanding current trends is crucial for effective public health interventions.

Purpose of the Study:

  • To provide an updated review of trichomoniasis.
  • To cover recent advancements in its epidemiology, pathophysiology, clinical significance, diagnosis, and treatment.
  • To inform healthcare providers and researchers on the latest developments.

Main Methods:

  • Literature review of recent studies on trichomoniasis.
  • Synthesis of current data on epidemiology and disease mechanisms.
  • Analysis of updated diagnostic and therapeutic guidelines.

Main Results:

  • The review details the global epidemiology of trichomoniasis, highlighting prevalence and risk factors.
  • It discusses the pathophysiology, including host-parasite interactions.
  • Current diagnostic methods and effective treatment options are presented.

Conclusions:

  • Trichomoniasis remains a significant global health concern requiring ongoing surveillance and management.
  • Updated knowledge on diagnosis and treatment is essential for reducing transmission and complications.
  • Further research may focus on novel therapeutic approaches and prevention strategies.